RBD-3075

N/A

Report date: 2025/04/11 14:13:21
NME

Base Information

Drug NameRBD-3075
Drug Alias NameRBD-3075RBD3075
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionAsialoglycoprotein receptor modulators
TargetsAsialoglycoprotein receptor
Therapy Area/IndicationsLipid Metabolism Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Ribo Life Science Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Ribo Life Science Co Ltd
Inactive CompaniesN/A
Active IndicationsLipid Metabolism Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A